Get Help Sign In
ProcessingProcessing

News

Psomagen Added to IDT Align Program

Jun 15, 2021
One of the leading providers of CLIA/CAP accredited genomic services becomes part of IDT’s program to increase accessibility of solutions to researchers
CORALVILLE, Iowa (June 15, 2021) – Integrated DNA Technologies, Inc. (IDT), a leader in comprehensive genomics research solutions, welcomes Psomagen, Inc., a United States-based genetic sequencing and data analysis service provider, to the IDT Align Program, further expanding the program’s roster of preferred sequencing partners. 

The IDT Align Program assists researchers by expanding access to services and solutions that help move genomic projects forward. IDT is partnering with quality service providers to make NGS tools and resources more accessible, especially for scientists who need sequencing services tailored to their projects. 

Psomagen specializes in customized genome services with an emphasis on early adoption of emerging technologies. Precise analysis of transcriptomes and genomes enables Psomagen to identify the role of genes, environments, and lifestyles. The generation of these insights in their CLIA certified labs can assist researchers in predicting the risk of disease and inform public health surveillance where appropriate. 

To expand their role in public health surveillance, Psomagen has partnered recently with Swift Biosciences (now a part of IDT), to offer comprehensive SARS-CoV-2 variant determination using next generation sequencing (NGS) and BTO qSanger for SARS-CoV-2 testing.   

“IDT welcomes Psomagen to the Align Program, another great addition to a program designed to offer key resources to NGS researchers,” said IDT President Trey Martin. “Psomagen is performing important work in surveillance for SARS-CoV-2 variant detection, bolstered by the implementation of Swift’s SNAP Panel into their workflow, and IDT aims to make these products and services more accessible to further combat the pandemic.”

“We are excited to work with IDT to bring sequencing-based applications to the forefront,” said Ryan Kim, Chief Executive Officer at Psomagen. “Not only to help address immediate needs related to the COVID-19 pandemic, but also to facilitate important work in other areas such as cancer and rare disease research.”

IDT is a leader in DNA writing, and the company is also delivering innovative and high-performing NGS products to enable research and discoveries. NGS solutions from IDT feature high reproducibility, customization, and scalability that break down barriers for scientists and enhance confidence in their results. 

Psomagen offers a wide array of sequencing services for all applications and species through its modern, fully equipped labs which are CLIA and CAP certified. Psomagen has extended its genetic technology services to scientists in North America for more than 15 years. 

For more information, visit www.idtdna.com

Follow @idtdna on Twitter for real-time updates and insights.

About IDT
Integrated DNA Technologies, Inc. (IDT)
develops, manufactures, and markets nucleic acid products for the life sciences industry in the areas of academic and commercial research, agriculture, medical diagnostics, and pharmaceutical development. IDT has developed proprietary technologies for genomics applications such as next generation sequencing, CRISPR genome editing, synthetic biology, digital PCR, and RNA interference. Through its GMP services, IDT manufactures products used by scientists researching many forms of cancer and most inherited and infectious diseases. IDT is widely recognized as the industry leader in custom nucleic acid manufacture, serving over 130,000 life sciences researchers. IDT was founded in 1987 and has its manufacturing headquarters in Coralville, Iowa, USA, with additional manufacturing sites in San Diego, California, USA; Research Triangle Park, North Carolina, USA; Leuven, Belgium; and Singapore. For more information, please visit www.idtdna.com

Media Contact
IDT Public Relations
800-328-2661 (USA & Canada)
+1 319-626-8400 (outside USA)
idtpr@idtdna.com


About Psomagen
Psomagen, Inc., formerly Macrogen USA, delivers genetic sequencing services to clinical, academic, and consumer markets. Psomagen’s labs are US-based and CLIA and CAP certified, which means they are accredited to perform high-quality next generation sequencing, Sanger sequencing, and microarray analysis. Learn more about Psomagen’s full array of sequencing services at www.psomagen.com
 

MEDIA INFORMATION

Learn about IDT's role in the fight against COVID-19

Media and PR

For media inquiries please contact IDT Public Relations, idtpr@idtdna.com